Taking into consideration of the enrichment of GO and KEGG, the Upframeshift 1 (UPF1), which is a tumor suppressor in HCC [19, 20, 22], was predicted to be a direct target of RBM47 (Fig. 3C, D). Here, UPF1 is linked to hepatocellular carcinoma.